Parkview Research Center; Parkview Health
Fort Wayne, Indiana, 46845, United States
NCT Number: NCT03018197
The purpose of this pilot study is to examine the use of a personal health record to improve medication adherence among patients with non-valvular atrial fibrillation taking dabigatran for primary prevention of embolic stroke.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Fort Wayne, Indiana, 46845, United States
Three brief newsletters will be sent by the research staff to the study patients in the form of secure messages through their MyChart account. The newsletters will describe dabigatran tolerability, adverse effects, patient monitoring, warnings/precautions, and administration. Newsletters will be developed through a review of the FDA-approved prescribing information, general tertiary references, and a search of PubMed and drafted with guidance from a Drug Information Specialist at Manchester University College of Pharmacy as well as reviewed by the research staff.
Descriptive analysis will be used to analyze the survey to assess patient attitudes and beliefs about dabigatran and personal health records, as well as to assess the level of patient engagement. Difference-in-difference regression analysis will be used to evaluate the impact of the personal health record on dabigatran adherence by comparing the differences between times (pre-post) and interventions. Patient medication adherence will be correlated from the Pharmacy refill data to determine if the Intervention Group is more compliant than the Control Group. Multivariate analysis will be used to explore factors influencing personal health record use and dabigatran adherence.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Medication education delivered via the personal health record (MyChart) pertinent to the anticoagulation medication dabigatran. Education newsletters will be sent at 4, 6, and 10 weeks post-enrollment.
Time frame: 3 months during study
Time frame: 3 months during study
Time frame: 3 months during study
Parkview Health
Other
The Use of Electronic Personal Health Records to Improve Medication Adherence Among Non-Valvular Atrial Fibrillation Patients: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03973931
Adherence, Medication, Arrhythmias, Cardiac
Aurora, Colorado, United States
View Trial DetailsNCT02690649
Arrhythmias, Cardiac, Atrial Fibrillation
Fort Wayne, Indiana, United States
View Trial DetailsNCT03280368
Anticoagulants; Circulating, Hemorrhagic Disorder, Arrhythmias, Cardiac
Herning, Mid-Jutland, Denmark
View Trial DetailsNCT04993807
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details